Patent details

300612 Product Name: 4-aminopyridine, dan wel een derivaat daarvan, in het bijzonder een zout, solvaat of prodrug.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300612
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2377536
Status:
Refused Art. 10 of the EC Regulations
Application number:
300612
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/11/699/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
20/07/2011
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
03/09/2013
First Marketing Authorization date:
20/07/2011
Grant date:
Activation date:
11/04/2025
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
26/10/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
27/01/2021

Applicant/holder

From:
03/09/2013
 
 

 

Name:
Acorda Therapeutics, Inc.
Address:
420 Saw Mill River Road, ARDSLEY, NY 10502, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
03/09/2013
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
04/21
Publication date:
27/01/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
44/15
Publication date:
28/10/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2013/38
Publication date:
18/09/2013
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
27/01/2021 Outgoing Correspondence Decision refusal 2 PDF /2/1/6/0/0/0400300612/docs/300612_8_391798l527a.pdf
26/10/2020 Outgoing Correspondence Letter to applicant 2 PDF /2/1/6/0/0/0400300612/docs/300612_11_374401l173.pdf
31/05/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/1/6/0/0/0400300612/docs/300612_0_incomingcorrespondencepaper20160602115729637.pdf
31/05/2016 SPC Documents Annex SPC 1 PDF /2/1/6/0/0/0400300612/docs/300612_10_supplprotectioncertificate20200304104920192.pdf
03/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /2/1/6/0/0/0400300612/docs/300612_6_outgoingcorrespondence20140603.pdf
26/05/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/1/6/0/0/0400300612/docs/300612_1_incomingcorrespondencepaper20140526.pdf
10/09/2013 Outgoing Correspondence Outgoing Letter 1 PDF /2/1/6/0/0/0400300612/docs/300612_4_outgoingcorrespondence20130910.pdf
09/09/2013 Outgoing Correspondence Outgoing Letter 1 PDF /2/1/6/0/0/0400300612/docs/300612_2_outgoingcorrespondence20130909.pdf
03/09/2013 Application Form Confirmed application form 3 PDF /2/1/6/0/0/0400300612/docs/300612_3_applicationform20130903.pdf
03/09/2013 SPC Documents Summary of the characteristics of the product 12 PDF /2/1/6/0/0/0400300612/docs/300612_5_supplprotectioncertificate20200304103747085.pdf
03/09/2013 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/1/6/0/0/0400300612/docs/300612_7_incomingcorrespondencepaper20130903.pdf
03/09/2013 SPC Documents Marketing Authorization SPC 4 PDF /2/1/6/0/0/0400300612/docs/300612_9_supplprotectioncertificate20200304104026241.pdf